drugset / Trial / NCT00535054

Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms

NCT00535054 ↗

Completed 125 enrolled Trima, Israel Pharmaceutical Products
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine safety and patients' satisfaction when using Tears Again to treat Dry Eye Symptoms.

Timeline

Start
2007-09
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tears Again Unknown — —

Indications